List of insiders holdings for Anebulo Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Lawler Joseph F. Director 10% Owner | 2022-10-04 16:13:36 | 2,030,425 10,000,000 | 12,030,425 | Form 4 |
English Aron R. 22NW LP 22NW Fund LP Director 10% Owner | 2023-12-20 16:22:01 | 0 10,020,818 | 10,020,818 | Form 4 |
Schneeberger Daniel Chief Executive Officer | 2021-05-06 20:41:15 | 982,500 0 | 982,500 | Form 3 |
Cunningham Richard Anthony Chief Executive Officer | 2023-10-11 17:25:20 | 600,000 0 | 600,000 | Form 4 |
Cundy Kenneth C Chief Scientific Officer | 2024-03-08 08:07:25 | 72,613 0 | 72,613 | Form 4/A |
ALLEN SIMON Chief Executive Officer | 2022-12-13 21:18:16 | 70,246 0 | 70,246 | Form 4 |
Calloway Nathaniel Director | 2022-11-02 16:31:58 | 59,149 0 | 59,149 | Form 4 |
Kupchyk Areta Director | 2022-10-03 19:51:09 | 30,425 0 | 30,425 | Form 4 |
Aryeh Jason Director | 2022-10-03 19:53:40 | 30,425 0 | 30,425 | Form 4 |
Parschauer Karah Herdman Director | 2022-10-03 19:56:01 | 30,425 0 | 30,425 | Form 4 |
Lin Kenneth Director | 2022-10-04 16:11:04 | 30,425 0 | 30,425 | Form 4 |
SHAH BIMAL R. Director | 2023-10-10 21:49:29 | 26,097 0 | 26,097 | Form 4 |
Merchant James R. Chief Financial Officer | 2021-05-06 20:43:30 | 0 0 | 0 | Form 3 |
GARDINER SANDRA A. Acting Chief Financial Officer | 2023-04-04 18:32:28 | 0 0 | 0 | Form 3 |
George Dan Chief Financial Officer | 2023-10-02 17:01:20 | 0 0 | 0 | Form 3 |